Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 4/20 | 0.50 |
| ▸ | CES1 | P23141 | 4/20 | 0.50 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19617979 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL96402 | 0.84 | KMT2A (0.50) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL8897012 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL29229899 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL11038929 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL2994225 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL4451253 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL15393198 | 0.84 | KMT2A (0.56) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL30467239 | 0.83 | KMT2A (0.50) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL27971770 | 0.83 | KMT2A (0.50) | KMT2AMAPTCES2CES1HAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12396941-B2 | Cosmetic composition that resists pilling | L'OREAL (FR) | 2025-08-26 | — | — | US | claimed |
| US-11819559-B2 | Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort | L'OREAL (FR) | 2023-11-21 | — | — | US | claimed |
| EP-4221665-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2023-08-09 | — | — | EP | claimed |
| CN-116367810-A | Cosmetic composition comprising an antimicrobial system for reducing eye irritation or discomfort | 欧莱雅 | 2023-06-30 | — | — | CN | claimed |
| US-11679072-B2 | Water-based smudge-resistant make-up remover | L'OREAL (FR) | 2023-06-20 | — | — | US | claimed |
| WO-2022072585-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2022-04-07 | — | — | WO | claimed |
| US-20220096345-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2022-03-31 | — | — | US | claimed |
| WO-2022047179-A1 | WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER | L'OREAL (FR) | 2022-03-03 | — | — | WO | claimed |
| US-20220062150-A1 | WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER | L'OREAL (FR) | 2022-03-03 | — | — | US | claimed |
| US-10638755-B2 | Antimicrobial compositions | SYMRISE AG (DE) | 2020-05-05 | — | — | US | claimed |
| US-20160015031-A1 | Antimicrobial Compositions | SYMRISE AG (DE) | 2016-01-21 | — | — | US | claimed |
| WO-2014135650-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2014-09-12 | — | — | WO | claimed |
| EP-4746843-A1 | NATURE-BASED FACIAL LIFTING MASK | L'OREAL (FR) | 2026-05-27 | — | — | EP | disclosed |
| US-20260115114-A1 | COSMETIC COMPOSITION THAT RESISTS PILLING | L'OREAL (FR) | 2026-04-30 | — | — | US | disclosed |
| US-20260102323-A1 | STABLE COSMETIC COMPOSITION WITH HIGH LEVEL OF ELECTROLYTES | L'OREAL (FR) | 2026-04-16 | — | — | US | disclosed |
| US-12582584-B2 | Oxidizer and acid based system and regimen for enhancing skin appearance | L'OREAL (FR) | 2026-03-24 | — | — | US | disclosed |
| US-20210093530-A1 | BIPHASE CHEMICAL PEEL | L'OREAL (FR) | 2021-04-01 | — | — | US | disclosed |
| WO-2021062208-A1 | BIPHASE CHEMICAL PEEL | L'OREAL (FR) | 2021-04-01 | — | — | WO | disclosed |
| WO-2021041312-A1 | SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING PROPERTIES | L'OREAL (FR) | 2021-03-04 | — | — | WO | disclosed |
| US-20210059921-A1 | SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING PROPERTIES | L'OREAL (FR) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582584-B2 | Oxidizer and acid based system and regimen for enhancing skin appearance | CUTA, PLOD2, HAO2 | KMT2A 3277/4885MAPT 4818/4885CES2 1335/4885 |
| US-10638755-B2 | Antimicrobial compositions | CUTA, ARG1, POLR1C | KMT2A 2113/4885MAPT 4444/4885CES2 4043/4885 |
| US-20220096345-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | GK, PIR, LAGE3 | KMT2A 3551/4885MAPT 4303/4885CES2 2582/4885 |
| US-11819559-B2 | Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort | GK, PIR, LAGE3 | KMT2A 3551/4885MAPT 4303/4885CES2 2582/4885 |
| US-20260102323-A1 | STABLE COSMETIC COMPOSITION WITH HIGH LEVEL OF ELECTROLYTES | PNISR, PRMT1, CUTA | KMT2A 101/4885MAPT 2263/4885CES2 4288/4885 |
| US-20260115114-A1 | COSMETIC COMPOSITION THAT RESISTS PILLING | CUTA, COL2A1, LIPA | KMT2A 1923/4885MAPT 2403/4885CES2 2838/4885 |
| US-20160015031-A1 | Antimicrobial Compositions | CUTA, ARG1, POLR1C | KMT2A 2113/4885MAPT 4444/4885CES2 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.